We love a clean scorecard in global health. Give bureaucrats a neat percentage, three consecutive milestones, and a tidy acronym, and they will throw a party. The latest nation to cross the finish line of the celebrated 95/95/95 HIV targets is popping champagne, plastering the achievement across press releases, and accepting polite applause from international agencies.
Everyone is cheering. Everyone is wrong.
I have spent two decades watching public health programs chase vanity metrics while the actual ground reality rots underneath the spreadsheets. I have seen ministries blow millions chasing diagnostic percentages while clinics run out of basic supplies. The global obsession with the 95/95/95 framework—95 percent diagnosed, 95 percent of those on antiretroviral therapy, and 95 percent of those virally suppressed—is a masterclass in measuring the wrong things with extreme precision.
Hitting these numbers feels good. It looks brilliant in an annual report to donors. But it masks a grim truth: a country can achieve epidemiological perfection on paper while its patients continue to suffer, slip through the cracks, and face systemic abandonment.
Let us dismantle the illusion.
The First Lie Is Diagnosis Without Destination
The entire architecture of the first ninety-five rests on a fundamental misreading of human behavior. The directive tells health systems to test everyone, everywhere, constantly. Push the numbers up. Maximize case finding.
Here is what happens when you turn testing into a bureaucratic quota. Clinics deploy mobile units to hand out rapid tests to people who have a near-zero risk profile, simply to check a box for regional coordinators. Meanwhile, high-risk populations—sex workers, intravenous drug users, men who have sex with men—stay deep in the shadows because the local clinics are run by moralistic gatekeepers who treat a positive result as a criminal indictment.
I remember standing in a peri-urban clinic a few years ago watching a nurse proudly brandish a ledger showing a ninety-eight percent diagnosis rate for the district. When I asked to see the retention numbers for those newly diagnosed individuals, she handed me a dusty box of unindexed referral cards. They knew who had the virus. They had zero idea if those human beings ever survived the journey home after hearing a life-altering sentence in a crowded, unventilated room.
Diagnosis is not healthcare. Diagnosis is data collection. When you treat testing as the finish line rather than the absolute starting pistol, you create a ledger of the damned—people whose status is known to the state, but whose subsequent care is left to chance.
The Second Lie Is Pills Without Lives
Let us move to the second ninety-five: getting ninety-five percent of diagnosed individuals onto antiretroviral therapy.
On paper, this sounds humane. Modern antiretroviral therapy is a marvel of modern pharmacology. Single-tablet regimens have transformed a death sentence into a manageable chronic condition. If you take the pill every day, you live a normal life, and you become virally suppressed, rendering the virus sexually untransmissible. U equals U. Undetectable equals untransmissible. It is a scientific triumph.
Here is the friction point that the global health consensus conveniently ignores: pills do not cure poverty, stigma, or structural violence.
Imagine a scenario where a twenty-four-year-old subsistence farmer in a rural district gets diagnosed and handed a thirty-day bottle of pills. Sounds like success, right? Now look closer. He has to walk twelve miles to the clinic every month because the transport infrastructure is crumbling. The clinic opens at eight in the morning and closes by noon, forcing him to choose between a day's wage in the fields and picking up his medication. When he arrives, the pharmacist lectures him for being late last month.
When you shove toxic, unsupportive living conditions onto a patient and then blame them for missing doses, you do not have a treatment failure. You have a system failure.
We measure pill distribution because it is easy to count shipping containers leaving a port in Durban or Mumbai. We do not count the psychological toll of a lifetime of forced medication adherence without nutritional support, stable housing, or mental health resources. We treat the virus like a mechanical glitch in an otherwise fine engine, ignoring that the engine is rusted through.
The Third Lie Is Suppression Without Safety
Then we reach the golden fleece: the final ninety-five, representing viral suppression among those on treatment.
This is where the victory laps reach a fever pitch. If the viral load drops below detectable levels, the mission is accomplished. The patient is safe. The epidemic is contained. The country gets its badge of honor.
Except viral suppression is a snapshot, not a permanent shield.
A patient can achieve viral suppression in January and lose it by July because their life fell apart. Their partner left them, their landlord evicted them, local police harassed them for carrying medication bottles, or inflation priced food out of their reach. Chronic stress alters immune function and compliance. A viral load test taken once a year tells you precisely nothing about the turbulent reality of an individual navigating daily survival.
Furthermore, focusing exclusively on viral suppression creates a blind spot for drug resistance and co-infections. We are seeing worrying trends of resistance to first-line and even second-line regimens in populations that were supposedly safely suppressed last quarter. When treatment programs operate like assembly lines focused on a single biological marker, they miss the creeping tide of multi-drug resistance until it is too late to contain.
The Metrics That Actually Matter
If we burned the 95/95/95 framework tomorrow, what should we replace it with? We need an operational shift from counting events to sustaining human beings.
We need to track ten-year retention. Not who walked through the door today, but who is still alive, healthy, and thriving a decade later.
We need to track stigma reduction indices. If a patient is terrified to disclose their status to their employer or family because the local community will ostracize them, your clinical targets are meaningless window dressing.
We need to track integrated multi-morbidity care. HIV does not exist in a biological vacuum. Patients are dealing with hypertension, diabetes, cervical cancer, mental health crises, and substance use disorders. A clinic that hands out antiretroviral drugs while ignoring a patient's skyrocketing blood pressure or untreated depression is not running a healthcare facility; it is a pharmacy with a waiting room.
Stop Celebrating The Wrong Victory
The country currently celebrating its 95/95/95 milestone has every right to acknowledge the hard work of its frontline clinicians and community health workers. Those individuals perform miracles daily with shoestring budgets and exhausted staff.
The national government, however, needs to stop using these numbers as a shield against criticism. Hitting an arbitrary international benchmark does not mean the fight is over. It often means the bureaucratic machinery has simply gotten better at counting the people it manages to reach while continuing to ignore the ones it leaves behind in the dark.
We do not need another celebratory summit. We need an honest reckoning with the limits of our metrics.
Put down the spreadsheets. Look at the human beings behind the numbers.
